Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

DBV Technologies (DBVT) Debt to Equity (2014 - 2020)

DBV Technologies (DBVT) reported Debt to Equity of $0.01 for Q2 2020, down 57.47% year-over-year from $0.01 in Q3 2019, and down 23.89% on a QoQ basis from $0.01 in Q4 2019.

DBV Technologies (DBVT) has 7 years of Debt to Equity data on file, last reported at $0.01 in Q2 2020.

  • Quarterly Debt to Equity fell 57.47% year-over-year to $0.01 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $0.01 (down 57.47% YoY) and the FY2019 annual result came in at $0.01, down 63.61% from the prior year.
  • Debt to Equity declined to $0.01 in Q2 2020 per DBVT's latest filing, from $0.01 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.03 in Q4 2017 and bottomed at $0.01 in Q2 2020.
  • The 5-year median for Debt to Equity is $0.02 (2018), against an average of $0.02.
  • The widest annual swing landed in 2016, when Debt to Equity sank 64.01%; it then jumped 67.18% in 2017.
  • Tracing DBVT's Debt to Equity over 5 years: stood at $0.02 in 2016, then jumped by 67.18% to $0.03 in 2017, then plunged by 36.01% to $0.02 in 2018, then plunged by 62.98% to $0.01 in 2019, then fell by 23.89% to $0.01 in 2020.
  • Per Business Quant, the three latest DBVT Debt to Equity figures stand at $0.01 (Q2 2020), $0.01 (Q4 2019), and $0.02 (Q3 2019).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.06
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 0.01
Dec 31, 2019 0.01
Sep 30, 2019 0.02
Jun 30, 2019 0.01
Dec 31, 2018 0.02
Jun 30, 2018 0.02
Dec 31, 2017 0.03
Jun 30, 2017 0.02
Dec 31, 2016 0.02
Jun 30, 2016 0.02
Dec 31, 2015 0.02
Jun 30, 2015 0.05
Dec 31, 2014 0.04